BLUEPRINT MEDICINES CORPORATION Increase (Decrease) in Unbilled Receivables
BLUEPRINT MEDICINES CORPORATION reported Increase (Decrease) in Unbilled Receivables of -$3.58 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-21.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2018-02-21
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for the quarter ending 2017-12-31 was -$3.44M, a 2915.57% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for the quarter ending 2017-09-30 was $360.00K, a 246.15% increase year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for the quarter ending 2017-06-30 was $249.00K.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for the quarter ending 2017-03-31 was -$751.00K, a 191.81% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for fiscal 2017 was -$3.58M, a 2294.48% decline from fiscal 2016.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for fiscal 2016 was $163.00K, a 95.23% decline from fiscal 2015.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in unbilled receivables for fiscal 2015 was $3.41M.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$3.08M derived: sum of 2 quarters · filed 2018-02-21 | -$2.83M derived: sum of 3 quarters · filed 2018-02-21 | -$3.58M 10-K · filed 2018-02-21 |
| 2017-09-30 | $360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $609.00K derived: sum of 2 quarters · filed 2017-10-31 | -$142.00K 10-Q · filed 2017-10-31 | -$20.00K derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$502.00K 10-Q · filed 2017-08-02 | -$380.00K derived: sum of 3 quarters · filed 2018-02-21 | -$276.00K derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-03-31 | -$751.00K 10-Q · filed 2017-05-03 | -$629.00K derived: sum of 2 quarters · filed 2018-02-21 | -$525.00K derived: sum of 3 quarters · filed 2018-02-21 | -$1.41M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $226.00K derived: sum of 2 quarters · filed 2018-02-21 | -$655.00K derived: sum of 3 quarters · filed 2018-02-21 | $163.00K 10-K · filed 2018-02-21 |
| 2016-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$777.00K derived: sum of 2 quarters · filed 2017-10-31 | $41.00K 10-Q · filed 2017-10-31 | $985.00K derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | -$881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$63.00K 10-Q · filed 2017-08-02 | $881.00K derived: sum of 3 quarters · filed 2018-02-21 | $1.43M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $818.00K 10-Q · filed 2017-05-03 | $1.76M derived: sum of 2 quarters · filed 2018-02-21 | $2.31M derived: sum of 3 quarters · filed 2018-02-21 | $3.75M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $944.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $1.49M derived: sum of 2 quarters · filed 2018-02-21 | $2.93M derived: sum of 3 quarters · filed 2018-02-21 | $3.41M 10-K · filed 2018-02-21 |
| 2015-09-30 | $547.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.99M derived: sum of 2 quarters · filed 2016-11-10 | $2.47M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.92M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $484.00K 10-Q · filed 2016-05-10 |